Promis Neurosciences Inc. · NASDAQ:PMN
Trails Edge Capital Partners, LP reported a 9.90% stake in Promis Neurosciences Inc. (Schedule 13G)
Event Feb 3, 2026 · Filed Feb 10, 2026
Trails Edge Capital Partners, LP reported a 9.90% stake in Promis Neurosciences Inc., 933,477 shares, as a passive investor on Feb 3, 2026. Filed Feb 10, 2026 (Schedule 13G).
- Stake
- 9.90%
- Shares
- 933,477
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Trails Edge Capital Partners, LP | 9.90% | 933,477 |
| Trails Edge Biotechnology Master Fund, LP | 9.90% | 933,477 |
| Ortav Yehudai | 9.90% | 933,477 |
Source
Related
- Promis Neurosciences Inc.
- Trails Edge Capital Partners, LP
- Promis Neurosciences Inc. shareholders
- Schedule 13G/A · Great Point Partners LLC · Aug 14, 2026
- Schedule 13G/A · Wellington Management Group LLP · Aug 13, 2026
- Schedule 13G/A · Wellington Biomedical Innovation Master Investors (Cayman) II, L.P. · Aug 13, 2026
- Form 4 · Kaplan Johanne · Aug 7, 2026
- Schedule 13G · Wellington Management Group LLP · May 15, 2026